These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 18520601)

  • 1. Effects of cyclosporine a on single-dose pharmacokinetics of intravenous itraconazole in patients with hematologic malignancies.
    Timmers GJ; Kessels LW; Wilhelm AJ; Veldkamp AI; Bosch TM; Beijnen JH; Huijgens PC
    Ther Drug Monit; 2008 Jun; 30(3):301-5. PubMed ID: 18520601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic evaluation of the drug interaction between intravenous itraconazole and intravenous tacrolimus or intravenous cyclosporin A in allogeneic hematopoietic stem cell transplant recipients.
    Leather H; Boyette RM; Tian L; Wingard JR
    Biol Blood Marrow Transplant; 2006 Mar; 12(3):325-34. PubMed ID: 16503502
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics and safety of a 7-day administration of intravenous itraconazole followed by a 14-day administration of itraconazole oral solution in patients with hematologic malignancy.
    Boogaerts MA; Maertens J; Van Der Geest R; Bosly A; Michaux JM; Van Hoof A; Cleeren M; Wostenborghs R; De Beule K
    Antimicrob Agents Chemother; 2001 Mar; 45(3):981-5. PubMed ID: 11181397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between cyclosporine concentration and genetic polymorphisms of CYP3A5 and MDR1 during the early stage after renal transplantation.
    Azarpira N; Aghdaie MH; Behzad-Behbahanie A; Geramizadeh B; Behzadi S; Malekhoseinie SA; Raisjalal GH; Rahsaz M; Pourgholami A; Sagheb F
    Exp Clin Transplant; 2006 Jun; 4(1):416-9. PubMed ID: 16827636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The cytochrome P450 3A4 inhibitor itraconazole markedly increases the plasma concentrations of dexamethasone and enhances its adrenal-suppressant effect.
    Varis T; Kivistö KT; Backman JT; Neuvonen PJ
    Clin Pharmacol Ther; 2000 Nov; 68(5):487-94. PubMed ID: 11103751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amlodipine, but not MDR1 polymorphisms, alters the pharmacokinetics of cyclosporine A in Japanese kidney transplant recipients.
    Kuzuya T; Kobayashi T; Moriyama N; Nagasaka T; Yokoyama I; Uchida K; Nakao A; Nabeshima T
    Transplantation; 2003 Sep; 76(5):865-8. PubMed ID: 14501869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of intravenous itraconazole in stable hemodialysis patients.
    Mohr JF; Finkel KW; Rex JH; Rodriguez JR; Leitz GJ; Ostrosky-Zeichner L
    Antimicrob Agents Chemother; 2004 Aug; 48(8):3151-3. PubMed ID: 15273137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics and safety of itraconazole in patients with cystic fibrosis.
    Conway SP; Etherington C; Peckham DG; Brownlee KG; Whitehead A; Cunliffe H
    J Antimicrob Chemother; 2004 May; 53(5):841-7. PubMed ID: 15044430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A prospective cross-over study comparing the pharmacokinetics of cyclosporine A and its metabolites after oral versus short-time intravenous cyclosporine A administration in pre-heart transplant patients.
    Lehle K; Kirchner GI; Rupprecht L; Gruber M; Birnbaum DE; Schmid FX; Preuner JG
    Transplant Proc; 2007 Dec; 39(10):3323-8. PubMed ID: 18089380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A pharmacokinetic and safety study of a novel polymeric paclitaxel formulation for oral application.
    Veltkamp SA; Alderden-Los C; Sharma A; Rosing H; Beijnen JH; Schellens JH
    Cancer Chemother Pharmacol; 2007 Jan; 59(1):43-50. PubMed ID: 16680462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Declining intracellular T-lymphocyte concentration of cyclosporine a precedes acute rejection in kidney transplant recipients.
    Falck P; Asberg A; Guldseth H; Bremer S; Akhlaghi F; Reubsaet JL; Pfeffer P; Hartmann A; Midtvedt K
    Transplantation; 2008 Jan; 85(2):179-84. PubMed ID: 18212621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of itraconazole and hydroxyitraconazole in healthy subjects after single and multiple doses of a novel formulation.
    Mouton JW; van Peer A; de Beule K; Van Vliet A; Donnelly JP; Soons PA
    Antimicrob Agents Chemother; 2006 Dec; 50(12):4096-102. PubMed ID: 16982783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravenous itraconazole followed by oral itraconazole in the treatment of invasive pulmonary aspergillosis in patients with hematologic malignancies, chronic granulomatous disease, or AIDS.
    Caillot D; Bassaris H; McGeer A; Arthur C; Prentice HG; Seifert W; De Beule K
    Clin Infect Dis; 2001 Oct; 33(8):e83-90. PubMed ID: 11550120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polymorphisms of multidrug resistance gene (MDR1) and cyclosporine absorption in de novo renal transplant patients.
    Foote CJ; Greer W; Kiberd B; Fraser A; Lawen J; Nashan B; Belitsky P
    Transplantation; 2007 May; 83(10):1380-4. PubMed ID: 17519790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Itraconazole and hydroxyitraconazole serum concentrations are reduced more than tenfold by phenytoin.
    Ducharme MP; Slaughter RL; Warbasse LH; Chandrasekar PH; Van de Velde V; Mannens G; Edwards DJ
    Clin Pharmacol Ther; 1995 Dec; 58(6):617-24. PubMed ID: 8529326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MDR1 C3435T polymorphisms correlate with cyclosporine levels in de novo renal recipients.
    Foote CJ; Greer W; Kiberd BA; Fraser A; Lawen J; Nashan B; Belitsky P
    Transplant Proc; 2006 Nov; 38(9):2847-9. PubMed ID: 17112845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of grapefruit juice on pharmacokinetics of itraconazole in healthy subjects.
    Kawakami M; Suzuki K; Ishizuka T; Hidaka T; Matsuki Y; Nakamura H
    Int J Clin Pharmacol Ther; 1998 Jun; 36(6):306-8. PubMed ID: 9660036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of palifermin administered as the standard dose and as a collapsed dose in patients with hematologic malignancies.
    Zia-Amirhosseini P; Hurd DD; Salfi M; Cheah TC; Aycock J; Cesano A
    Pharmacotherapy; 2007 Oct; 27(10):1353-60. PubMed ID: 17896890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blood concentration curve of cyclosporine: impact of itraconazole in lung transplant recipients.
    Irani S; Fattinger K; Schmid-Mahler C; Achermann E; Speich R; Boehler A
    Transplantation; 2007 Apr; 83(8):1130-3. PubMed ID: 17452906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ABCB1 genotype of the donor but not of the recipient is a major risk factor for cyclosporine-related nephrotoxicity after renal transplantation.
    Hauser IA; Schaeffeler E; Gauer S; Scheuermann EH; Wegner B; Gossmann J; Ackermann H; Seidl C; Hocher B; Zanger UM; Geiger H; Eichelbaum M; Schwab M
    J Am Soc Nephrol; 2005 May; 16(5):1501-11. PubMed ID: 15772250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.